Gossamer Bio Correlations
GOSS Stock | USD 0.70 0.04 6.06% |
The current 90-days correlation between Gossamer Bio and Biomea Fusion is 0.16 (i.e., Average diversification). The correlation of Gossamer Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Gossamer Bio Correlation With Market
Average diversification
The correlation between Gossamer Bio and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Gossamer Bio and DJI in the same portfolio, assuming nothing else is changed.
Gossamer |
Moving together with Gossamer Stock
0.7 | HLN | Haleon plc | PairCorr |
0.73 | LLY | Eli Lilly | PairCorr |
0.62 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.82 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.71 | RDY | Dr Reddys Laboratories | PairCorr |
0.68 | TAK | Takeda Pharmaceutical | PairCorr |
0.71 | ZTS | Zoetis Inc | PairCorr |
0.64 | ABBV | AbbVie Inc Sell-off Trend | PairCorr |
0.73 | AMGN | Amgen Inc | PairCorr |
0.71 | ANEB | Anebulo Pharmaceuticals | PairCorr |
0.71 | APGE | Apogee Therapeutics, | PairCorr |
Moving against Gossamer Stock
0.81 | VTRS | Viatris | PairCorr |
0.64 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
0.6 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
0.39 | GILD | Gilead Sciences | PairCorr |
0.34 | WAT | Waters | PairCorr |
0.78 | DXCM | DexCom Inc Sell-off Trend | PairCorr |
0.72 | MNMD | Mind Medicine | PairCorr |
0.57 | EW | Edwards Lifesciences Corp | PairCorr |
0.55 | BSX | Boston Scientific Corp Sell-off Trend | PairCorr |
0.52 | ABT | Abbott Laboratories Sell-off Trend | PairCorr |
0.49 | NBIX | Neurocrine Biosciences | PairCorr |
0.4 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.38 | MOLN | Molecular Partners | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Gossamer Stock performing well and Gossamer Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Gossamer Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BMEA | 3.46 | (0.17) | 0.00 | (0.07) | 0.00 | 9.12 | 24.44 | |||
STOK | 2.61 | (0.33) | 0.00 | (0.13) | 0.00 | 4.68 | 21.35 | |||
AKRO | 2.37 | 0.13 | 0.07 | 0.19 | 2.66 | 5.23 | 13.37 | |||
FIXX | 2.82 | 0.04 | 0.01 | 0.16 | 3.52 | 5.77 | 19.43 | |||
REPL | 3.36 | 0.45 | 0.13 | 0.37 | 3.38 | 8.25 | 46.30 | |||
NVCT | 4.37 | (0.34) | 0.00 | 0.00 | 0.00 | 10.84 | 75.91 | |||
LYRA | 4.16 | (0.78) | 0.00 | (0.48) | 0.00 | 8.00 | 41.07 | |||
KRON | 2.63 | (0.04) | (0.03) | (0.04) | 3.32 | 5.75 | 16.20 | |||
PASG | 5.09 | (0.25) | (0.01) | 0.02 | 5.96 | 10.00 | 25.50 | |||
BDTX | 3.53 | (1.50) | 0.00 | (0.59) | 0.00 | 5.47 | 19.51 |
Gossamer Bio Corporate Management
Colin Rowlings | Senior CMC | Profile | |
Robert Smith | Chief Officer | Profile | |
Matt Cravets | Senior Biometrics | Profile | |
Jeff Boerneke | General Secretary | Profile | |
Richard MD | Chief Officer | Profile | |
Mario Orlando | Senior Planning | Profile |